Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity
- PMID: 17917113
- DOI: 10.1007/s12035-007-0030-1
Roles of transient receptor potential vanilloid subtype 1 and cannabinoid type 1 receptors in the brain: neuroprotection versus neurotoxicity
Abstract
Transient receptor potential vanilloid subtype 1 (TRPV1), also known as vanilloid receptor 1 (VR1), is a nonselective cation channel that is activated by a variety of ligands, such as exogenous capsaicin (CAP) or endogenous anandamide (AEA), as well as products of lipoxygenases. Cannabinoid type 1 (CB1) receptor belongs to the G protein-coupled receptor superfamily and is activated by cannabinoids such as AEA and exogenous Delta-9-tetrahydrocannabinol (THC). TRPV1 and CB1 receptors are widely expressed in the brain and play many significant roles in various brain regions; however, the issue of whether TRPV1 or CB1 receptors mediate neuroprotection or neurotoxicity remains controversial. Furthermore, functional crosstalk between these two receptors has been recently reported. It is therefore timely to review current knowledge regarding the functions of these two receptors and to consider new directions of investigation on their roles in the brain.
Similar articles
-
The endogenous cannabinoid anandamide inhibits transient receptor potential vanilloid type 1 receptor-mediated currents in rat cultured primary sensory neurons.Acta Physiol Hung. 2010 Jun;97(2):149-58. doi: 10.1556/APhysiol.97.2010.2.1. Acta Physiol Hung. 2010. PMID: 20511124
-
Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.Endocrinology. 2009 Oct;150(10):4692-700. doi: 10.1210/en.2009-0057. Epub 2009 Jul 16. Endocrinology. 2009. PMID: 19608651
-
Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.J Neurosci. 2003 May 15;23(10):4127-33. doi: 10.1523/JNEUROSCI.23-10-04127.2003. J Neurosci. 2003. PMID: 12764100 Free PMC article.
-
Why do cannabinoid receptors have more than one endogenous ligand?Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3216-28. doi: 10.1098/rstb.2011.0382. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108541 Free PMC article. Review.
-
Interplay between endocannabinoid and endovanilloid mechanisms in fear conditioning.Acta Neuropsychiatr. 2024 Oct;36(5):255-264. doi: 10.1017/neu.2023.54. Epub 2023 Nov 20. Acta Neuropsychiatr. 2024. PMID: 37982167 Review.
Cited by
-
Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.Channels (Austin). 2015;9(2):102-13. doi: 10.1080/19336950.2015.1009272. Channels (Austin). 2015. PMID: 25713995 Free PMC article.
-
The Endocannabinoid Signaling System in the CNS: A Primer.Int Rev Neurobiol. 2015;125:1-47. doi: 10.1016/bs.irn.2015.10.001. Epub 2015 Nov 6. Int Rev Neurobiol. 2015. PMID: 26638763 Free PMC article. Review.
-
Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.Trends Pharmacol Sci. 2009 Feb;30(2):79-84. doi: 10.1016/j.tips.2008.10.008. Epub 2008 Dec 11. Trends Pharmacol Sci. 2009. PMID: 19070372 Free PMC article. Review.
-
Research progress in transient receptor potential vanilloid 1 of sensory nervous system.Neurosci Bull. 2009 Aug;25(4):221-7. doi: 10.1007/s12264-009-0506-2. Neurosci Bull. 2009. PMID: 19633705 Free PMC article. Review.
-
Epoxyeicosanoid signaling in CNS function and disease.Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):68-84. doi: 10.1016/j.prostaglandins.2009.06.004. Epub 2009 Jun 21. Prostaglandins Other Lipid Mediat. 2010. PMID: 19545642 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous